Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1097 - 1104 of 11616 results
Energy & Sustainability Litigation Updates — July 2023
July 25, 2023| Article| Viewpoint
Energy & Sustainability Event Highlights — July & August 2023
July 25, 2023| Article| Viewpoint
Why Pharma Companies Should File Patents Later In The R&D Process
July 25, 2023| Blog| Viewpoint
First Nonprescription Birth Control Pill Approved for Marketing by FDA: A Milestone for Reproductive Health
July 25, 2023| Blog| Viewpoint
California’s Highest Court Revisits Statutory PAGA Standing: What the Ruling Means for California Employers
July 25, 2023| Blog| Viewpoint
Why Is ‘Fiduciary’ Losing Its Luster?
July 25, 2023| News
Employers Need to Go Further to Accommodate an Employee’s Religion
July 24, 2023| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.